Cellanome

Redwood City, United States

Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.

$150.0M raised

Jan 2024

Series B

Top Investors

Premji InvestSynetro Group

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cellanome raised?

Cellanome has raised $150.0M in total funding. The most recent round was Series B. The last funding was announced in January 2024.

Who are Cellanome's investors?

Cellanome's investors include Premji Invest, Synetro Group.

Where is Cellanome headquartered?

Cellanome is headquartered in Redwood City, United States.

What does Cellanome do?

Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.

What stage is Cellanome at?

Cellanome is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 29, 2024.

MLA

"Cellanome — Funding & Investors." VCBacked, January 29, 2024, https://www.vcbacked.co/company/cellanome. Accessed June 17, 2026.

APA

VCBacked. (2024). Cellanome — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/cellanome

Wikipedia (cite web)

{{cite web |title=Cellanome — Funding & Investors |url=https://www.vcbacked.co/company/cellanome |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 29, 2024.